Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BR

Bo Ren — 14 Patents

BEBeigene: 12 patents #5 of 41Top 15%
PFPurdue Research Foundation: 1 patents #1,409 of 3,174Top 45%
Honeywell: 1 patents #11,900 of 16,504Top 75%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Bo Ren has been granted 14 US patents while listed as an inventor at Beigene. The first was granted in 2016 and the most recent in September 2025. Bo Ren ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Bo Ren in Beijing, NJ, CN.

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12404517 Rhizobial tRNA-derived small RNAs and uses thereof for regulating plant nodulation Jianxin Ma, Jingbo Duan, Xutong Wang 2025-09-02
11202782 Treatment cancers using a combination comprising PARP inhibitors Lai-Xi Wang, Zhiyu Tang, Lusong Luo, Min Wei, Kang Li +4 more 2021-12-21 $86,031,000
10882856 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases Hexiang Wang, Yunhang Guo, Zhiwei Wang, Guoliang Zhang, Changyou Zhou 2021-01-05 $149,657,000
10823670 Compact ultraviolet light adsorption sensing system Yubin LV, Junfeng Wang, Li Wang 2020-11-03 $63,504,000
10647714 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases Hexiang Wang, Guoliang Zhang, Yunhang Guo, Zhiwei Wang, Changyou Zhou 2020-05-12 $96,094,000
10501467 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Hexiang Wang 2019-12-10 $95,456,000
10457680 Process for preparing a PARP inhibitor, crystalline forms, and uses thereof Hexiang Wang, Changyou Zhou, Xianzhao Kuang 2019-10-29 $62,841,000
10280163 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases Hexiang Wang, Guoliang Zhang, Yunhang Guo, Zhiwei Wang, Changyou Zhou 2019-05-07 $55,702,000
10112952 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Hexiang Wang 2018-10-30 $59,054,000
9827226 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Changyou Zhou, Hexiang Wang 2017-11-28 $29,091,000
9617273 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Hexiang Wang 2017-04-11 $7,927,000
9393232 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Changyou Zhou, Hexiang Wang 2016-07-19 $3,106,000
9328111 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors Changyou Zhou, Hexiang Wang 2016-05-03 $3,441,000
9260440 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Hexiang Wang 2016-02-16